Home > Insider Trading > Filing (0001765581-25-000042)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1232524	Jazz Pharmaceuticals Plc	JAZZ	Pharmaceutical Preparations (2834)	981032470

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1536639	Seamus Mulligan	5Th Fl, Waterloo Exchange Waterloo Rd Dublin 4 L2		Yes	No	No	No

Transaction Summary

Purchased:	101,621 shares	Avg. Price: $98.34	Total Value: $9,993,081.71
Number of Shares After Transactions:	101,621 shares

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Ordinary Shares	Acquisiton	2025-05-09	80,684	$98.10	80,684	No	4	P	Indirect	By Nerano Pharma Lim
Ordinary Shares	Acquisiton	2025-05-09	19,216	$98.91	99,900	No	4	P	Indirect	By Nerano Pharma Lim
Ordinary Shares	Acquisiton	2025-05-09	100	$99.71	100,000	No	4	P	Indirect	By Nerano Pharma Lim
Ordinary Shares	Acquisiton	2025-05-12	1,621	$103.00	101,621	No	4	P	Indirect	By Nerano Pharma Lim

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By Nerano Pharma Lim
No	4	P	Indirect	By Nerano Pharma Lim
No	4	P	Indirect	By Nerano Pharma Lim
No	4	P	Indirect	By Nerano Pharma Lim

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Ordinary Shares	1,176,106	Direct

Footnotes

Reflects the purchase of ordinary shares executed in multiple transactions at prices ranging from $97.56 to $98.5542. The price reported reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the purchases were effected.
Shares beneficially owned by Nerano Pharma Limited, an entity owned and controlled by the reporting person and his immediate family.
Reflects the purchase of ordinary shares executed in multiple transactions at prices ranging from $98.56 to $99.47. The price reported reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the purchases were effected.
Reflects the purchase of ordinary shares executed in multiple transactions at prices ranging from $102.97 to $103.00. The price reported reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the purchases were effected.